Clinical Trial Detail

NCT ID NCT02999633
Title Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia (ISLAY)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Sanofi
Indications

T-cell adult acute lymphocytic leukemia

T-cell childhood acute lymphocytic leukemia

Therapies

Isatuximab

Age Groups: child senior adult

No variant requirements are available.